Discover 1,705 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,705
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
for
Asthma
Location: Detroit MI, Windsor, Toledo OH, Cleveland OH, Hamilton,
Sponsor: AstraZeneca
Sex: All
Age: 5 - 11
Code: NCT06023589
Phase3, Recruiting
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
for
Metastatic Prostate Cancer
Location: Detroit MI, Ann Arbor MI, New York NY, Providence RI,
Sponsor: AstraZeneca
Sex: Male
Age: 18 - 70+
Code: NCT07181161
Phase1, Phase2, Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
for
Asthma
Location: Detroit MI, Toledo OH, Findlay OH, Columbus OH,
Sponsor: AstraZeneca
Sex: All
Age: 12 - 17
Code: NCT06307665
Phase3, Recruiting
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
for
Relapsed AL Amyloidosis, Refractory AL Amyloidosis,
Location: Detroit MI, Cleveland OH, Toronto, St Louis MO,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07081646
Phase1, Phase2, Recruiting
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Detroit MI, Fort Wayne IN, North Chicago IL,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06350097
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
for
Breast Cancer
Location: Detroit MI, Cleveland OH, Hamilton, Toronto, Barrie,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06103864
Phase3, Recruiting
New
ICG Fluorescence in Knee Arthroscopy Study
for
To Assess the Feasibility, Visualization Capability, and Optimal Dosing of ICG Fluorescence Imaging for Intraoperative Assessment of Knee Tissue Perfusion,
Location: Detroit MI, Cleveland OH, Silver Spring MD,
Sponsor: Direct Biologics, LLC
Sex: All
Age: 18 - 70+
Code: NCT05354141
Phase3, Recruiting
NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection
for
Coronavirus Infection, Severe Acute Respiratory Infection,
Location: Detroit MI, Chicago IL, Bethesda MD, Washington DC,
Sponsor: Biomed Industries, Inc.
Sex: All
Age: 18 - 70+
Code: NCT04452565
Phase2, Phase3, Recruiting
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
for
Amyotrophic Lateral Sclerosis (ALS)
Location: Detroit MI, Pittsburgh PA, Richmond VA,
Sponsor: Zydus Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT07023835
Phase2, Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Detroit MI, Farmington MI, Rochester Hills MI,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06433752
Recruiting
Understanding Pathways to Wellness and Recovery in Detroit - Digital Recovery Support Services
for
Alcohol Use Disorder, Recovery Outcomes, Digital Health
Location: Detroit MI
Sponsor: Brandeis University
Sex: All
Age: 18+
Code: NCT07724275
Recruiting
Peer-Delivered Behavioral Activation in a CCBHC
for
Major Depressive Disorder, Substance Use Disorders
Location: Detroit MI
Sponsor: Wayne State University
Sex: All
Age: 18+
Code: NCT07219394
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
for
Non-Small Cell Lung Cancer, NSCLC,
Location: Detroit MI, Cleveland OH, Pittsburgh PA, Fairfax VA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06162221
Phase1, Phase2, Recruiting
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
for
Multiple Myeloma
Location: Detroit MI, Ann Arbor MI, Montreal, Deerfield Beach FL,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06057402
Recruiting
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
for
Advanced Solid Tumor
Location: Detroit MI, Cleveland OH, Grand Rapids MI,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07070232
Phase1, Phase2, Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
for
Breast Neoplasms
Location: Detroit MI, Winchester VA, Decatur IL, Allentown PA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06926868
Phase2, Phase3, Recruiting
Community Based Treatment for (ComBaT) Glaucoma
for
Glaucoma
Location: Detroit MI
Sponsor: University of Michigan
Sex: All
Age: 40+
Code: NCT06124521
Recruiting
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer,
Location: Detroit MI, Cleveland OH, Hamilton, Toronto, Buffalo NY,